Researchers at Washington University and Stanford developed a cannabinoid compound that provides pain relief without ...
A study published in the journal Decision Analysis unveils a powerful new tool to tackle the opioid crisis, offering a ...
Persica Pharma announces positive phase 1b Modic trial of PP353, a novel, non-opioid intradiscal injection to treat chronic low back pain: London, UK Thursday, March 6, 2025, 18:0 ...
By Alexandra Alter When Barbara Kingsolver was writing “Demon Copperhead,” a novel that explores the devastating effects of the opioid crisis in southern Appalachia, she was doubtful that ...
SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through ...
The opioid-free group also had improved comfort and satisfaction scores. Perspective from Asif M. Ilyas, MD, MBA, FAAOS According to published results, a novel opioid-free pathway may provide ...
The global opioid analgesics market is poised for substantial growth, projected to expand from USD 43.3 billion in 2023 to USD 72.0 billion by 2033, at a robust Compound Annual Growth Rate (CAGR) of 5 ...
First Drug Approved in New Class of Non-Opioid Pain Medicines; Agency Continues to Take Steps to Support New Approaches for Pain Management SILVER SPRING, Md., Jan. 30, 2025 /PRNewswire/ -- Today ...
DOI: 10.1287/deca.2023.0084 Provided by Institute for Operations Research and the Management Sciences Citation: Novel tool slashes opioid crisis costs by 30%, could save lives (2025, February 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback